Diagnostic and Therapeutic Challenges.
Federico
F
Corvi
Rosangela
R
Lattanzio
Elisabetta
E
Miserocchi
Lea
L
Querques
Francesco
F
Bandello
Giuseppe
G
Querques
Daniel E
DE
Croft
Charles C
CC
Wykoff
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D001766:Blindness / Q000175:diagnosis; D001813:Blood-Retinal Barrier; D002199:Capillary Permeability; D003937:Diagnosis, Differential; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D017075:Laser Coagulation; D008875:Middle Aged; D055213:Retinal Pigment Epithelium / Q000473:pathology*; D058456:Retinal Telangiectasis / Q000175:diagnosis* / Q000628:therapy; D012171:Retinal Vessels / Q000473:pathology*; D058471:Subretinal Fluid; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity
D020533:Angiogenesis Inhibitors; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A